# Negative feedback circuit for toll like receptor-8 activation in human embryonic Kidney 293 using outer membrane vesicle delivered bi-specific siRNA

**Authors:** Anurag Adhikari, Birendra Prasad Gupta, Krishna Das Manandhar, Shravan Kumar Mishra, Hari Krishna Saiju, Rajendra Maan Shrestha, Nawneet Mishra, Shishir Sharma

PMC · DOI: 10.1186/s12865-015-0109-9 · BMC Immunology · 2015-07-23

## TL;DR

This study presents a bi-specific siRNA system that activates TLR8 and silences MyD88 in a controlled way using bacterial vesicles, potentially offering a new approach for managing immune-related diseases.

## Contribution

A novel bi-specific siRNA delivery system using outer membrane vesicles for negative feedback regulation of TLR8 and MyD88.

## Key findings

- Outer membrane vesicles with invasive protein Ail and OmpA efficiently deliver siRNA to HEK293-TLR8 cells.
- siRNA complexed with p19 activates TLR8, increasing INFβ production significantly.
- Fusogenic peptides enable siRNA escape from endosomes to silence MyD88 transcripts.

## Abstract

TLR8 assists in antiviral approach by producing Type 1 INF via MyD88 dependent IRF7 pathway. However, over expression of INFα/β molecule poses threat by developing tolerance in chronic infection cases and enhancing inflammatory response. Here we report a bi-specific siRNA based complex which differentially activates and silences the TLR8 and MYD88 respectively in a negatively regulated fashion.

Outer membrane vesicle from Escherichia coli used for siRNA delivery was observed more efficient when attached with invasive protein Ail along with OmpA (P < 0.001) in HEK293-TLR8 cell line. siRNA complexed with p19 protein was efficient in activating TLR8, confirmed by the increment of INFβ molecules (P < 0.001) in HEK293-TLR8 compared to its counterpart. Fusion of lipid bilayer of endosomal compartment was significant at pH 4.5 when fusogenic peptides (diINF-7) were incubated in membrane vesicle, thus facilitating the escape of siRNA complex to the host cytoplasm in order to silence MyD88 transcript (P < 0.001).

We investigated the activation of TLR8 by bi-specific si-RNA for the production of INFβ. In the same setting we showed that bi-specific si-RNA was able to silence MyD88 transcript in a delayed manner. For the cases of auto immune disease and inflammation where over activation of endosomal TLRs poses serious threat, bi specific siRNA could be used as negative feedback controlled system.

The online version of this article (doi:10.1186/s12865-015-0109-9) contains supplementary material, which is available to authorized users.

## Linked entities

- **Genes:** TLR8 (toll like receptor 8) [NCBI Gene 51311], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615], IRF7 (interferon regulatory factor 7) [NCBI Gene 3665], infB (translation initiation factor 2) [NCBI Gene 809886]
- **Proteins:** MYD88 (MYD88 innate immune signal transduction adaptor), CDKN2A (cyclin dependent kinase inhibitor 2A), ail (IDS4-like protein), ompa (olfactory marker protein a)
- **Diseases:** auto immune disease (MONDO:0007179)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, IFNA17 (interferon alpha 17) [NCBI Gene 3451] {aka IFN-alphaI, IFNA, INFA, LEIF2C1}, IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654] {aka IRAK, pelle}, TAT (tyrosine aminotransferase) [NCBI Gene 6898], IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) [NCBI Gene 60489] {aka A3G, ARCD, ARP-9, ARP9, CEM-15, CEM15}, Rev [NCBI Gene 155908], IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, SIGIRR (single Ig and TIR domain containing) [NCBI Gene 59307] {aka IL-1R8, TIR8}, IFI6 (interferon alpha inducible protein 6) [NCBI Gene 2537] {aka 6-16, FAM14C, G1P3, IFI-6-16, IFI616}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, BST2 (bone marrow stromal cell antigen 2) [NCBI Gene 684] {aka CD317, HM1.24, TETHERIN}, CISH (cytokine inducible SH2 containing protein) [NCBI Gene 1154] {aka BACTS2, CIS, CIS-1, G18, SOCS}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TLR8 (toll like receptor 8) [NCBI Gene 51311] {aka CD288, IMD98, TLR-8, hTLR8}, IRF7 (interferon regulatory factor 7) [NCBI Gene 3665] {aka IMD39, IRF-7, IRF-7H, IRF7A, IRF7B, IRF7C}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, TRIM5 (tripartite motif containing 5) [NCBI Gene 85363] {aka RNF88, TRIM5alpha}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD81 (CD81 molecule) [NCBI Gene 975] {aka CVID6, S5.7, TAPA1, TSPAN28}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IRAK3 (interleukin 1 receptor associated kinase 3) [NCBI Gene 11213] {aka ASRT5, IRAKM}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MX2 (MX dynamin like GTPase 2) [NCBI Gene 4600] {aka MXB}, CLDN1 (claudin 1) [NCBI Gene 9076] {aka CLD1, ILVASC, SEMP1}, SOCS1 (suppressor of cytokine signaling 1) [NCBI Gene 8651] {aka AISIMD, CIS1, CISH1, JAB, SOCS-1, SSI-1}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}
- **Diseases:** DC infection (MESH:D054221), ulcerative colitis (MESH:D003093), chronic inflammation (MESH:D007249), OMVs (MESH:D015433), viral infection (MESH:D014777), SIV (OMIM:270100), Type 1 INF (MESH:D003922), 1 INF (MESH:C538557), IBD (MESH:D015212), infection (MESH:D007239), Crohn's (MESH:D003424), auto immune disease (MESH:C538437), HIV/SIV infection (MESH:D015658), inflammatory cytokines (MESH:D000080424), HBV infection (MESH:D006509), Cytotoxicity (MESH:D064420), death (MESH:D003643)
- **Chemicals:** sodium acetate (MESH:D019346), U (MESH:D014501), guanidinium thiocyanate (MESH:C054436), arabinose (MESH:D001089), peptides (MESH:D010455), glucose (MESH:D005947), PVDF (MESH:C024865), EDTA (MESH:D004492), L-glutamine (MESH:D005973), citric acid (MESH:D019343), GU (MESH:D019791), penicillin (MESH:D010406), lipid (MESH:D008055), ORNs (MESH:D009843), hydrogen chloride (MESH:D006851), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), sodium (MESH:D012964), disodium hydrogen phosphate (MESH:C018279), sodium citrate (MESH:D000077559), colchicine (MESH:D003078), DMEM (-), TRIzol (MESH:C411644), Neomycin (MESH:D009355), PBS (MESH:D007854), sodium chloride (MESH:D012965), IPTG (MESH:D007544),  (MESH:D016899),  (MESH:C526543),  (MESH:D037521)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Qubevirus faecium (species) [taxon 39804], HCV [taxon 11103], Human immunodeficiency virus 1 (no rank) [taxon 11676], Helicobacter pylori (species) [taxon 210], Homo sapiens (human, species) [taxon 9606], Yersinia pestis (species) [taxon 632]
- **Cell lines:** -7.gfp — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_DF45), HEK-TLR8 — Homo sapiens (Human), Transformed cell line (CVCL_IM79), 7.OmpA.p19 — Mus musculus (Mouse), Hybridoma (CVCL_J271), 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), pSB1C3.Ail.diINF-7.OmpA.saporin.torA — Cricetulus griseus (Chinese hamster), Transformed cell line (CVCL_8845)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4510891/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4510891/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC4510891/full.md

---
Source: https://tomesphere.com/paper/PMC4510891